ESP Block in Robotic Cardiac Surgery
Heart Valve Diseases, Postoperative Pain, Acute, Analgesia
About this trial
This is an interventional treatment trial for Heart Valve Diseases focused on measuring Robotic Cardiac Surgery, ESP Block, Postoperative Pain, Heart Valve disease
Eligibility Criteria
Inclusion Criteria: Robotic Cardiac Surgery Accepts to participate Exclusion Criteria: Use of other regional anesthesia technics Presence of chronic Pain Psychiatric pathology, drug abuse Allergy or intolerance to local anesthetics
Sites / Locations
- Hospital Clínic de BarcelonaRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Morphine infusion
ESP Block analgesia
IV morphine 50mcg/kg/h infusion with Patient Controlled Analgesia extra bolus on demand of 1mg (lockout interval 20 minutes), and paracetamol 1g every 8 hours.
After induction of anesthesia in the operating room, the patient is positioned in lateral decubitus. Under strict aseptic conditions, and guided by ultrasound, an Erector Spinae Plane block is performed injecting ropivacaine 0.2% 20ml, and a catheter is placed. An infusion of ropivacaine 0.16% at 10ml/h is started in the operating room. Patient Controlled Analgesia pump will be connected with 1mg IV morphine bolus on demand, and paracetamol 1g every 8 hours, is also delivered.